1. Impact of supplementation with "multivitamin-mineral" specially formulated to improve fatigue and inflammatory state in patients with multiple sclerosis: A triple-blind, randomized, placebo-controlled trial

Sama Bitarafan; Elmira Karimi; Abdorreza Naser Moghadasi; Razieh Sadat Kazemi-Mozdabadi; Zinat Mohammadpour; Mohammad Ali Sahraian

Volume 19, Issue 4 , Autumn 2020, , Pages 180-189

http://dx.doi.org/10.18502/cjn.v19i4.5545

Abstract
  Background: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with the most common complaint of fatigue. A high number of patients with MS are interested in taking dietary supplements as a complementary therapy. We propose a specially formulated supplement for patients ...  Read More

2. Prevalence of depression among Iranian patients with myasthenia gravis during 2017-2018

Kiana Amani; Payam Sarraf; Alireza Abkhoo; Abbas Tafakhori; Farzad Fatehi; Sama Bitarafan; Elmira Agah; Mamak Shariat

Volume 19, Issue 4 , Autumn 2020, , Pages 162-166

http://dx.doi.org/10.18502/cjn.v19i4.5542

Abstract
  Background: Myasthenia gravis (MG) is a chronic neuromuscular disease, which physically and mentally affects the patient’s life, with depression being one of the most important psychological complications in these patients. This study aims to investigate the prevalence of depression and its associated ...  Read More

3. The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations

Hedayat Abbastabar; Sama Bitarafan; Mohammad Hossein Harirchian

Volume 18, Issue 3 , Summer 2019, , Pages 134-142

Abstract
  Neurological disease contributes significantly to morbidity and mortality in different ages and geographic areas around the world. The purpose of the current study was to investigate the incidence and disability-adjusted life years (DALYs) trend of neurological disease in Iran during 27 years ago. We ...  Read More

5. Molecular mechanisms of omega-3 fatty acids in the migraine headache

Neda Soveyd; Mina Abdolahi; Sama Bitarafan; Abbas Tafakhori; Payam Sarraf; Mansoureh Togha; Ali Asghar Okhovat; Mahsa Hatami; Mohsen Sedighiyan; Mahmoud Djalali; Niyaz Mohammadzadeh-Honarvar

Volume 16, Issue 4 , Autumn 2017, , Pages 210-217

Abstract
  Migraine is a common chronic inflammatory neurological disease with the progressive and episodic course. Much evidence have shown a role of inflammation in the pathogenesis of migraine. Omega-3 fatty acids are an important components of cell membranes phospholipids. The intake of these fatty acids is ...  Read More

6. The comparison of anti-seizure and tocolytic effects of phenytoin and magnesium sulphate in the treatment of eclampsia and preeclampsia: A randomised clinical trial

Maryam Khooshideh; Majid Ghaffarpour; Sama Bitarafan

Volume 16, Issue 3 , Summer 2017, , Pages 125-129

Abstract
  Background: To date, magnesium sulphate (MgSO4) is the treatment of choice for prevention of seizure in eclampsia and preeclampsia. However, there are some limitations in the administration of MgSO4 due to its tocolytic effects. The aim of this study was to compare the anticonvulsant and tocolytic effects ...  Read More